SCHEME 3. Synthesis of 3
(2E,6E,10E)-12-Hydroxyfarnesol (1). Saponification of 30 (30
mg, 0.11 mmol) with K2CO3 (45 mg) in MeOH (4 mL) was
achieved in 20 min at rt to give 120 (26 mg, 99%).
(2E,6E,10E)-14-Hydroxy-3,7,11,15-tetramethylhexadeca-
2,6,10,15-tetraenyl Acetate (32). According to the procedure
described for the preparation of 30 and 31, the resulting crude from
treating 24 with AgBF4 was purified by column chromatography
(hexane/t-BuOMe, 2.5:1) on silica gel to afford 3321 (37%) along
with 32 (39%). Data for 32: IR (film) 3430, 2924, 2854, 1740,
1651, 1447, 1383, 1233 and 1024 cm-1 1H NMR (400 MHz;
;
CDCl3) δ 1.55-1.65 (2H, m), 1.59 (3H, s), 1.61 (3H, s), 1.70 (3H,
s), 1.72 (3H, s), 1.76 (1H, s, OH), 1.90-2.15 (10H, m), 2.04 (3H,
s), 4.03 (1 H, t, J ) 6.4 Hz), 4.58 (2H, d, J ) 7.1 Hz), 4.83 (1H,
s), 4.93 (1H, s), 5.09 (1H, t, J ) 6.3 Hz), 5.14 (1H, t, J ) 6.4 Hz),
5.34 (1H, dt, J ) 6.3, 1.0 Hz); 13C NMR (100 MHz; CDCl3) δ
16.0, 16.5, 17.7, 21.1, 26.2, 26.6, 33.2, 35.8, 39.5, 39.6, 61.5, 75.6,
111.0, 118.3, 123.8, 124.7, 134.8, 135.4, 142.3, 147.5, 171.2;
HRFABMS calcd for C22H36O3Na [M + Na]+ 371.2562, found
371.2571. According to the procedure described for the conversion
of 31 into 30, the transformation of 32 into 33 via mesylation and
subsequent hydrolysis with acetone/H2O proceeded in a 45% yield.
constitutes an additional plus of this protocol. This reaction has
been applied to the rapid and efficient synthesis of three
interesting hydroxyterpenoids.
Experimental Section
General Procedure for Allylic Chlorination of Polyolefinic
Polyprenoids Using NCS/Polymer-Supported Selenelyl Bromide.
Commercially available solid-supported selenenyl bromide (0.05
mmol) was dissolved in DCM (6 mL). To this solution was added
the corresponding acyclic polyolefinic polyprenoid (1.0 mmol) at
rt. To this mixture was added N-chlorosuccinimide (1.1 mmol) (TLC
monitoring). The solution was concentrated and then suspended
with diethyl ether. The organic layer was decanted from the solid,
washed with H2O and brine, dried over anhydrous Na2SO4, and
concentrated under reduced pressure. The resulting crude was
purified by column chromatography on silica gel to afford the
corresponding secondary allylic chloro derivative.
16-Hydroxygeranylgeraniol (2). Saponification of 33 (53 mg,
0.15 mmol) with K2CO3 (52 mg, 0.38 mmol) in MeOH (6 mL)
was achieved in 20 min at rt to give 24 (45 mg, 98%).
(6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyltetracosa-
1,6,10,14,18,22-hexaen-3-ol (3). According to the procedure de-
scribed for the preparation of 30 and 31, the resulting crude from
treating the mixture of 26 and 27 (3:1 ratio) with AgBF4 was
purified by column chromatography (hexane/t-BuOMe, 2.5:1) on
silica gel to afford 35 (26%) and the primary alcohol (2E,6E,10E,-
14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-
hexaen-1-ol22 (20%) along with (2E,6E,10E,14E,18E)-2,6,10,15,-
19,23-hexamethyltetracosa-2,6,10,14,18,23-hexaene-1,22-diol (9%)
and (2E,6E,10E,14E,18E,22E)-2,6,10,15,19,23-hexamethyltetracosa-
2,6,10,14,18,22-hexaene-1,24-diol4 (6%). Data for (2E,6E,10E,
14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,23-
hexaene-1,22-diol: IR (film) 3387, 2922, 2855, 1658, 1446, 1382
(2E,6E)-10-Hydroxy-3,7,11-trimethyldodeca-2,6,11-trienyl Ac-
etate (31). (2E,6E)-10-Chloro-3,7,11-trimethyldodeca-2,6,11-trienyl
acetate (18) obtained by regioselective chlorination of farnesyl
acetate (750 mg, 2.51 mmol) was dissolved in acetone (25 mL),
and then H2O (50 mL), 2,4,6-collidine (1.34 mL, 10.0 mmol), and
AgBF4 (973 mg, 5.0 mmol) were added. The resulting mixture was
refluxed at 60-70 °C for 1 h (TLC monitoring). Then, acetone
was removed under reduced pressure and the residue was extracted
with EtOAc (3 × 20 mL). The organic layer was washed with 2 N
HCl and brine, dried over anhydrous Na2SO4, and concentrated
under reduced pressure, and the resulting crude was purified by
column chromatography (hexane/t-BuOMe, 2.5:1) on silica gel to
afford 3019 (280 mg, 40%) and 31 (312 mg, 45%). Data for 31:
IR (film) 3453, 2967, 2938, 2856, 1740, 1446, 1382, 1367, 1234,
1023, 954, 898 cm-1; 1H NMR (400 MHz; CDCl3) δ 1.54 (3H, s),
1.55-1.68 (2H, m), 1.63 (3H, s), 1.66 (3H, s), 1.85-2.12 (6H,
m), 1.98 (3H, s), 3.96 (1H, t, J ) 6.5 Hz), 4.51 (2H, d, J ) 7.1
Hz), 4.76 (1H, q, J ) 1.5 Hz), 4.86 (1H, t, J ) 0.9 Hz), 5.07 (1H,
1
and 1014 cm-1; H NMR (400 MHz; CDCl3) δ 1.55-1.65 (2H,
m), 1.59 (12H, s), 1.65 (3H, s), 1.71 (3H, s), 1.93-2.15 (18H, m),
3.98 (2H, s), 4.03 (1H, t, J ) 6.3 Hz), 4.83 (1H, t, J ) 1.6 Hz),
4.93 (1 H, s), 5.13 (4H, m), 5.38 (1 H, dt, J 6.9, 1.2 Hz); 13C NMR
(100 MHz; CDCl3) δ 13.8, 16.1, 17.7, 26.4, 26.7, 28.4, 33.3, 35.8,
39.4, 39.8, 39.8, 69.1, 75.7, 111.0, 124.5, 124.5, 124.7, 124.9, 126.3,
134.6, 134.7, 134.8, 135.1, 135.1, 147.6; HRFABMS calcd for
C30H50O2Na [M + Na]+ 465.3709, found 465.3694.
Acknowledgment. This research was supported by the
Spanish Ministry of Science and Technology (Project BQU
2002-03211). We thank Dr. M. J. de la Torre for revising our
English text.
dt, J ) 6.8 Hz, J ) 1.2 Hz), 5.28 (1H, tq, J ) 7.1 Hz, 1.2 Hz); 13
C
NMR (100 MHz; CDCl3) δ 16.0, 16.5, 17.7, 21.1, 26.1, 33.2, 35.7,
39.5, 61.5, 75.6, 111.0, 118.5, 124.2, 135.2, 142.1, 147.6, 171.2;
HRFABMS calcd for C17H28O3Na [M + Na]+ 303.1936, found
303.1934. To a solution of 31 (145 mg, 0.51 mmol) in 5 mL of
pyridine at 0 °C was added DMAP (cat.). After 10 min, MsCl (0.88
mL, 3.0 mmol) was added. The reaction mixture was stirred for 1
h, quenched with saturated aqueous NaHCO3, extracted with
t-BuOMe, washed with 1 N HCl, NaHCO3, and brine, dried over
anhydrous Na2SO4, and concentrated under reduced pressure. The
resulting crude was dissolved in acetone (5 mL) and H2O (4 mL),
and then NaOAc (100 mL) was added. The mixture was heated at
reflux for 2 h. The resulting crude was purified by column
chromatography (hexane/t-BuOMe, 2:1) on silica gel to afford 31
(53 mg, 38%) and 30 (57 mg, 41%), improving in this way the
efficiency of the process.
Supporting Information Available: Experimental procedures
1
and spectroscopic data of new compounds and H and 13C NMR
spectra of 1-3, 6, 10, 12, 16, 18, 24, 29a, 31, and 32. This material
JO060760D
(19) Li, J.; Lan, J.; Liu, Z.; Li, Y. J. Nat. Prod. 1998, 61, 92-95.
(20) DeBarber, A. E.; Bleyle, L. A.; Roullet, J.-B. O.; Koop, D. R.
Biochim. Biophys. Acta 2004, 1682, 18-27.
(21) Cox, N. J. G.; Mills, S. D.; Pattenden, G. J. Chem. Soc., Perkin
Trans. 1 1992, 11, 1313-1321.
(22) Sen, S. E.; Prestwich, G. D. J. Med. Chem. 1989, 32, 2152-2158.
5814 J. Org. Chem., Vol. 71, No. 15, 2006